As one of the most commonly prescribed weight-loss medications among the adult population, phentermine is a sympathomimetic amine that works as an appetite suppressant secondary to its CNS effects and is approved for short-term (12-week) treatment of weight management in adolescents aged 16 years and older with a BMI 30 kg/m 2 or a BMI 27 kg/m 2 and 1 weight-associated comorbidity
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analog of human IGF-1, engineered to overcome the pharmacokinetic limitations of the native hormone
the potential for adverse regulatory action in Canada, the United States, or other applicable jurisdictions in respect of the Companys peptide products, including actions by Health Canada, the U.S
Though many are close to the finish line with efficacy and oral delivery, one that eliminates the gastro side-effects has yet to be seen
17% in the placebo group), but without achieving improvement of fibrosis